Vaccines and Global Health: The Week in Review 11 Nov 2017

Vaccines and Global Health: The Week in Review is a weekly digest  summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated with the current issue date

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

 pdf version A pdf of the current issue is available here: Vaccines and Global Health_The Week in Review_11 Nov 2017

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy

Milestones : Perspectives – National Foundation for Infectious Diseases Announces Prestigious 2018 Award Recipients

National Foundation for Infectious Diseases Announces Prestigious 2018 Award Recipients

BETHESDA, Md., Nov. 9, 2017 /PRNewswire-USNewswire/ — The National Foundation for Infectious Diseases (NFID) has selected Roger I. Glass, M.D., Ph.D., as recipient of the 2018 Jimmy and Rosalynn Carter Humanitarian Award, Kathryn M. Edwards, M.D., as recipient of the 2018 Maxwell Finland Award for Scientific Achievement and Anne Schuchat, M.D. (Rear Adm., U.S. Public Health Service), as recipient of the 2018 John P. Utz Leadership Award.

In recognition of his extraordinary contributions to public health over several decades and his outstanding leadership in research and vaccine policy which have helped to improve the health of children worldwide in the prevention of rotavirus, through the use of vaccines, NFID has selected Roger I. Glass, M.D., Ph.D., to receive the 2018 Jimmy and Rosalynn Carter Humanitarian Award.

“For three decades, Dr. Glass has been a global champion for research on rotavirus, the development of safe, effective and affordable rotavirus vaccines and for their inclusion in national programs for childhood immunization. Dr. Glass is not only an outstanding internationally recognized scientist but also a tireless advocate for health equity and delivery of the most effective vaccines to children throughout the world. Beyond these scientific and policy contributions, Dr. Glass has trained and mentored countless young investigators, many of whom are now in leadership positions worldwide. He has instilled in trainees a love for science, academic rigor and integrity, and a commitment to the public good,” said Mathuram Santosham, M.D., M.P.H., professor in the Department on International Health and Pediatrics at Johns Hopkins University.

In presenting the 2018 Maxwell Finland Award for Scientific Achievement, NFID recognizes Kathryn M. Edwards, M.D., as one of the world’s authorities on vaccinology, pediatric respiratory infections and pneumococcal disease. A member of the National Academy of Medicine, Dr. Edwards has made seminal discoveries in pediatric infectious diseases with work ranging from basic discovery, translational research, clinical trials and implementation. “Based on the myriad contributions to science that Dr. Edwards has made over her illustrious career, the tangible ways in which she has trained new generations of physicians and scientists, and the lasting impact her work will have, as well as her tireless dedication to the field, demonstrate how deeply deserving of this award she truly is. All who know her would echo my sentiment that she is one of the giants of pediatric infectious diseases,” said C. Buddy Creech, M.D., M.P.H., associate professor of Pediatrics in the Division of Pediatric Infectious Diseases at Vanderbilt University School of Medicine.

Anne Schuchat, M.D. (Rear Adm., U.S. Public Health Service), has been selected to receive the 2018 John P. Utz Leadership Award in recognition of her demonstrated skillful, unselfish leadership in trying times, including long-standing service to the Centers for Disease Control and Prevention and support to NFID. The award was established in honor of the late John P. Utz, M.D., one of the original founders of NFID.

The 2018 awards will be presented during the 45th anniversary of NFID, at the 2018 NFID Annual Awards Dinner on May 10, 2018 in Washington, D.C.

 

::::::

::::::

 

Milestones :: Perspectives – G7 Milan Health Ministers’ Communiqué – 5-6 November, 2017

Milestones :: Perspectives

Editor’s Note:

We recognize the inherent limitations of high-level communiques from multilateral meetings such at the G7, etc. But we present excerpts from the communique issued at last week’s G7 Health Ministers meeting in Milan which represent, in our view, constructive recognition of some key issues. Full test of the communique available at title link.

  G7 Milan Health Ministers’ Communiqué  – 5-6 November, 2017

“United towards Global Health: common strategies for common challenges”

[9 pages; Editor’s excerpts/text bolding]

PREAMBLE

  1. We recognize the importance of improving emergency preparedness, as well as crisis management and response, in cases of weather-related, and other disasters, epidemics and other health emergencies. In this respect, we welcome the consultation, led by the Italian Presidency and with international experts, providing science-based considerations to support informed decisions. We are determined to coordinate efforts, foster innovation, and share knowledge, information, and monitoring and foresight tools, to support the resilience of health systems and to protect the health of our populations. We underline the need to safeguard the protection of health workers and facilities during emergencies and in conflict-affected areas as provided by international humanitarian law.

 

  1. In line with previous G7 and G20 commitments and the objectives set by the 2030 Agenda for Sustainable Development and its Sustainable Development Goals (SDGs), we reiterate the importance of strengthening health systems through each country’s path towards Universal Health Coverage (UHC), leaving no one behind, and of preventing health systems from collapsing during humanitarian and public health emergencies and effectively mitigating health crises. We will work together to implement the Sendai Framework for Disaster Risk Reduction. We seek to reduce global inequalities; to protect and improve the health of all individuals throughout their life course through inclusive health services; to tackle non-communicable diseases (NCDs); to sustain our commitments to eradicate polio through support to the Global Polio Eradication Initiative, and to end the epidemics of HIV/AIDS, malaria and tuberculosis by 2030 through the support to the Joint UN Programme on HIV/AIDS (UNAIDS), the Global Fund to Fight AIDS, Tuberculosis and Malaria, and UNITAID; to support key global initiatives such as Gavi the Vaccine Alliance; and to invest in research and innovation important to global health.

 

  1. As the world gets closer to achieving global polio eradication, we also recognize the importance of continuing our efforts to succeed and keep the world sustainably polio‐free, and, of the opportunity to leverage and transition polio assets and resources that have generated major and broader health benefits, including strengthened health systems.

 

  1. We acknowledge the central leadership and coordinating role of WHO in country capacity building in preparing for and responding to public health emergencies, building resilient health systems, and the new strategic priority of WHO leadership to address the health impacts of climate and environmental factors. We acknowledge that WHO’s financial and human resource capacities have to be strengthened, including through adequate and sustainable funding of the WHO Emergency Programme and the Contingency Fund for Emergencies (CFE). We will explore supporting the World Bank’s Pandemic Emergency Financing Facility (PEF) and the WHO programme on environmental degradation and other determinants of health.

IMPACTS OF ENVIRONMENTAL FACTORS ON HEALTH

  1. We welcome and support the provision of health services, particularly including immunization programs for migrants and refugees, including in situations of forced displacement and protracted crises, as well as the improvement of health services in transit and destination countries. This includes making immunization programs and clinical services available and accessible to everyone, while increasing the surveillance of infectious diseases and the monitoring of NCDs and their risk factors.

 

  1. We will seek to improve access to physical and mental health services and assistance to migrants, refugees and crisis affected populations as appropriate. We will promote the identification, sharing, and adoption of good practices to address psychosocial needs of refugees and migrants. Following the adoption of the New York Declaration for Refugees and Migrants in September 2016, and the Resolution WHA 70.15 in May 2017, the support for migrants and refugees should consider their specific needs, leaving no one behind, in line with the 2030 Agenda for Sustainable Development.

GENDER PERSPECTIVE IN HEALTH POLICIES AND RIGHTS FOR WOMEN, CHILDREN AND ADOLESCENTS

  1. We invite the OECD to benchmark mental health performance focusing specifically on adolescents. We condemn sexual and gender-based violence that impacts women and girls across the globe. We need to demonstrate our commitment and our leadership in addressing sexual and gender‐based violence, including harmful practices such as child, early and forced marriage, and female genital mutilation, in line with SDG 5.2 and 5.3, and human trafficking, including for the purpose of sexual exploitation.

 

  1. We will support and empower women’s, children’s and adolescents’ voices, and meaningful participation through our policy, advocacy and programmatic engagement on health and nutrition and actively involve also men and boys as agents of change.

 

  1. We will seek to invest in their education, improving their health literacy, skills, and capacities, including children and adolescents’ gender and diversity-sensitive sexuality education, programmes, and tools.

ANTIMICROBIAL RESISTANCE

  1. We will promote R&D for new antimicrobials, alternative therapies, vaccines and rapid-point-of care diagnostics, in particular for WHO-defined priority pathogens and tuberculosis. We endeavor to preserve the existing therapeutic options. We see at this as a first step towards the acceleration of political commitments and urgent coordination, we look forward to the report to the United Nations General Assembly on AMR and the High Level Meeting on Tuberculosis in 2018.

CONCLUSIONS

  1. We recognize the urgent need to build political momentum on the importance of addressing the impacts of environmental degradation and other factors on health and coordinated action for strengthening health systems, in line with aid effectiveness principles. This includes addressing health workforce shortages and poor health financing by countries to achieve their goals of increasing access to health care. We welcome WHO, World Bank, UNICEF, and relevant partners, including OECD, joint action for supporting countries to achieve SDG 3.8, and look forward to the progress reported at the UHC Forum 2017 next month in Tokyo.

 

  1. We acknowledge the particular challenges of delivering health services in fragile states and conflict‐affected areas, where health systems are often compromised and ill-equipped to respond. Moreover, medical personnel and facilities in areas of conflict are increasingly under attack. Highlighting UN Security Council Resolution 2286 (2016) and UN General Assembly Resolution A RES/69/132 and UNGA 71/129, we strongly condemn violence, attacks, and threats directed against medical personnel and facilities, which have long term consequences for the civilian population and the healthcare systems of the countries concerned, as well as for the neighbouring regions. We therefore commit to improving their safety and security by upholding International Humanitarian Law.

 

  1. We reiterate our commitment to build our International Health Regulations (IHR) core capacities and to assist 76 partner countries and regions to do the same. We also recognize the importance of developing national plans to address critical health security gaps as notably identified using the WHO’s Joint External Evaluation tool. We call on all countries to make specific commitments to support full implementation of the IHR and recognize their compliance with IHR as essential for efficient global health crisis prevention and management. We encourage other countries and development partners to join these collective efforts.

 

Yemen

Yemen

Geneva Palais Briefing Note: The impact of the closure of all air, land and sea ports of Yemen on children
This is a summary of what was said by Meritxell Relano, UNICEF Representative in Yemen – to whom quoted text may be attributed – at today’s press briefing at the Palais des Nations in Geneva.
[Editor’s text bolding]
GENEVA, 10 November 2017 – Yemen is facing the largest humanitarian crisis and the worst food crisis in the world. Nearly 7 million people do not know where their next meal will come from and the survival of millions of people depends on humanitarian assistance operations.  You have all seen the statements from the humanitarian community in Yemen and from the Emergency Relief Coordinator based on his last visit on the ground. Fuel, medicines and food are essential in this context. And in order to get them in, we need access.

ACCESS
The recent closure of the Yemen’s airspace, sea and land ports has worsened the already shrinking space for the lifesaving humanitarian work. It is blocking the delivery of vital humanitarian assistance to children in desperate need in Yemen. And it is making a catastrophic situation for children far worse. The port of Hodeida is where most of the humanitarian supplies enter and it is essential that the port resumes its activity.

Also, because missions on the ground are not possible, blocking the movement of humanitarian workers and supplies, this means that millions of children will be deprived of lifesaving humanitarian assistance.

IMPACT
Let me give you some examples of the impact of the closure of the entry points to the country:
The current stocks of fuel will only last until the end of November. We need fuel to maintain health centers open and water systems functioning (both for distributing water and for treating used water). The price of existing fuel has increased by 60%.
If fuel stocks are not replenished:
:: UNICEF’s ongoing WASH response to respond to the cholera outbreak is likely to be affected. This could impact nearly 6 million people living in cholera high-risk districts.
:: The operating water supply systems and waste water treatment plants will stop functioning, causing unimaginable risks.
:: The functionality and mobility of the Rapid Response Teams, serving nearly half a million every week, will be hindered.
:: Due to shortage of fuel supply, 22 Governorates/District cold rooms/district vaccine stores are at a major risk of being shut down. Vaccines for thousands of children could be damaged.
If vaccines are blocked from reaching Yemen, at least 1 million children under the age of one will be at risk of diseases including polio and measles:

…The current stock of vaccines in the country will last 1 month
…Shortage of medical supplies will only worsen the Diphtheria outbreak recently reported in five districts of Ibb. About 87 suspected cases were reported with nine associated deaths.
With more than 60 per cent of population food insecure, the closure of the Yemen’s airspace, sea and land ports will lead to more deterioration in food security level which will worsen malnutrition rates.
Children are suffering from severe malnutrition and diseases that could be easily prevented. Children need urgent care and any disruption in bringing in therapeutic nutrition supplies will only mean that more children in Yemen will die.
UNICEF calls on all parties to the conflict in Yemen to allow and facilitate safe, sustainable, rapid and unhindered humanitarian access to all children and families in need, through land, air and sea.
 
::::::
 
WHO warns that more people will die if ports in Yemen do not reopen to humanitarian aid
Statement
9 November 2017 | GENEVA – For the fourth consecutive day, WHO’s operations in Yemen have been severely hampered due to the closure of all land, sea and air ports.

“WHO and the other humanitarian agencies need immediate and unhindered humanitarian access to Yemen”, said WHO Executive Director for Emergencies Dr Peter Salama. “The country is still facing the world’s largest cholera outbreak and 7 million people are on the brink of famine, including some two million severely malnourished children. If we can’t bring food and medical supplies into Yemen we will not be able to save people’s lives.”

WHO’s supplies are critically low. On Wednesday, WHO was prevented from delivering 250 tonnes of medical supplies via sea. The supply ship could not leave Djibouti as previously planned because of the closure of Yemen’s Al-Hudaydah’s port. The ship was carrying surgical kits, anaesthesia machines, infant incubator sets, water purification tablets and other essential supplies.

“We are particularly worried with the low stock of trauma kits”, said WHO representative in Yemen, Dr Nevio Zagaria. “We have enough for 2,000 surgeries but because of the escalating conflict we have treated hundreds of trauma patients in the last few weeks alone. If the hostilities continue and the ports remain closed, we will not be able to perform life-saving surgeries or provide basic health care.”

The closure of the ports will also affect the response to the cholera outbreak. As of 5 November, a total of 908,400 suspected cases and 2192 deaths have been reported since 27 April 2017 in 22 of 23 governorates. “We have made progress and there have been fewer deaths from cholera but we will suffer a major setback if we don’t have full access to all affected areas”, said Dr Zagaria.

Providing emergency health services and supporting partners in Yemen is a top priority for WHO. So far in 2017, WHO has provided 1500 tonnes of medicines and supplies. WHO-supported mobile medical teams have provided 21,443 consultations. WHO-supported surgical teams have conducted 9300 surgical interventions.
 

  Bangladesh steps up vaccination for new Rohingya arrivals as measles cases rise

Bangladesh – Measles Immunization
 
Bangladesh steps up vaccination for new Rohingya arrivals as measles cases rise

Joint press release

COX’S BAZAR, Bangladesh, 10 November 2017 – An increase in the number of suspected measles cases among the newly arrived Rohingya and their host communities in southern Bangladesh has prompted the Government and UN partners to step up immunization efforts in overcrowded camps and makeshift shelters close to the border with Myanmar.

Nearly 360 000 people in the age group of six months to 15 years among the new Rohingya arrivals in Cox’s Bazar and their host communities, irrespective of their immunization status, would be administered measles and rubella vaccine through fixed health facilities, outreach vaccination teams, and at entry points into Bangladesh.

Measles, a childhood killer disease which can be particularly dangerous among unimmunized and malnourished children, is one of the major health risks among the over 611,000 people who have crossed over to Bangladesh from Myanmar since late August and are now living in cramped and insanitary conditions in Cox’s Bazar district.

As of 4 November, one death and 412 suspected cases of measles have been reported among the vulnerable populations living in camps, settlements, and among the host communities in Cox’s Bazar. Of them, 352 cases are from Ukhia and 46 from Teknaf sub-districts, and 11 have been reported from the district hospital. Majority of cases – 398 – are among the new arrivals and 14 among the host communities. As many as 82% cases are among children under five years of age.

“Children are especially at risk from outbreaks of measles and other communicable diseases that result from the crowded living conditions, malnutrition and severe lack of water and sanitation in the camps and other sites,” said Edouard Beigbeder, UNICEF Bangladesh Representative. “To halt any wider outbreak, it’s essential that coordinated efforts begin immediately to protect as many children as possible.”

With the risk of measles being high during such health emergencies, Ministry of Health and Family Welfare (MoHFW), with support of WHO, UNICEF and other local partners, was quick to roll out a measles and rubella (MR) vaccination campaign, between 16 September and 4 October, within weeks of the start of the recent influx of Rohingyas from Myanmar. Nearly 136,000 children between six months and 15 years were administered MR vaccine. Additionally, around 72,000 children up to five years of age were given bivalent oral polio vaccine (bOPV) and a dose of Vitamin A to help prevent measles related complication. The number of new arrivals has increased since the MR campaign, which also had challenges reaching out to all children in view of movement of people within the camps and settlements.

“As part of stepped up vaccination efforts, 43 fixed health facility sites, 56 outreach vaccination teams and vaccination teams at main border entry points will administer MR vaccine to population aged six months to 15 years, along with oral polio vaccine to children under five years and TT vaccine to pregnant women. These efforts are aimed at protecting and preventing the spread of measles among the vulnerable population,” WHO Representative to Bangladesh, Dr N Paranietharan, said.

More than 70 vaccinators from government and partners have been trained to deliver routine vaccination though fixed sites and outreach teams beginning tomorrow, while vaccination at entry points at Subrang, Teknaf, is ongoing since 1 November.

The fixed sites and outreach teams will also cover under two year olds with vaccines available in Bangladesh EPI schedule, such as BCG, pentavalent vaccine, oral polio vaccine, pneumococcal vaccine and two doses of MR vaccine.

As an additional measure, resources to treat measles cases are being reinforced with the distribution of vitamin A supplements, antibiotics for pneumonia and Oral Rehydration Salt (ORS) for diarrhoea related to measles. To improve hygiene conditions among the refugee population, 3.2 million water purification tablets and a total of 18,418 hygiene kits have been distributed benefitting 92,090 people.

The current initiative is yet another massive vaccination drive being rolled out for the new arrivals from Myanmar and their host communities in Cox’s Bazar since 25 August this year.  After covering 136 000 people in the September- October MR campaign, MoHFW and partners administered 900 000 doses of oral cholera vaccine to these vulnerable populations in two phases. The first phase that started 10 October covered over 700 000 people aged one year and above – both the new arrivals and their host communities, while the second phase from 4 – 9 November provided an addition dose of OCV to 199,472 children between one and five years, for added protection and bOPV to 236,696 children under 5 years of age

Emergencies

Emergencies
 
POLIO
Public Health Emergency of International Concern (PHEIC)
Polio this week as of 1 November 2017 [GPEI]
:: Health Ministers at the G7 summit in Milan this week reaffirmed their commitment to polio eradication, recognising “the importance of continuing our efforts to succeed and keep the world sustainably polio-free”.
[See Milestones above for polio eradication reference]

:: Summary of newly-reported viruses this week:
Afghanistan: One new wild poliovirus type 1 (WPV1) case, reported in Batikot district in Nangarhar province.
Syria:  Ten new circulating vaccine derived poliovirus type 2 (cVDPV2) cases reported, eight in Mayadeen district, and two in Boukamal district, Deir Ez-Zor governorate. Four new cVDPV2 positive contacts reported, three in Mayadeen district, and one in Boukamal district, Deir Ez-Zor governorate.

::::::

Syria cVDPV2 outbreak situation report 21: 7 November 2017
Situation update 7 November 2017
:: Ten (10) new cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) were reported this week from Mayadeen and Boukamal districts, Deir Ez-Zor governorate. Isolates from some cases had been laboratory pending for some time. The most recent case (by date of onset) remains 25 August.
:: The total number of cVDPV2 cases is 63.
:: Inactivated polio vaccine (IPV) will be offered to children 2-23 months in areas of Damascus and Rural Damascus with large internally displaced populations in the upcoming subnational immunization days (SNIDs) targeting children under 5 with bivalent oral polio vaccine. The campaign is planned for 19 November.
:: 250,000 doses of IPV have arrived in Damascus, which will ensure a continuous supply of vaccine for routine immunization activities in coming months. Syria is finalizing planning for targeted vaccination with IPV and is finalizing a request for additional IPV vaccine for additional campaign activities in Hasakah, Aleppo, Damascus and Rural Damascus governorates.
:: The International Monitoring Board (the polio programmes highest independent review mechanism) met last week in London to assess progress towards global interruption of all poliovirus circulation. The IMB reviewed the quality of the Syrian outbreak response to date and will provide recommendations through its report on how Syria can strengthen its outbreak response activities in coming months.

::::::

Polio Eradication Hopes and Fears: What Next?
4 Nov, 201:
On the occasion of World Polio Day  
Heidi Larson, Ph.D. & Will Schulz, MSc,
[See Research/Commentary below for full text]
 
::::::
::::::

WHO Grade 3 Emergencies  [to 11 November 2017]
The Syrian Arab Republic
:: Syria cVDPV2 outbreak situation report 21: 7 November 2017
 [See Polio above]

Yemen
[See UNICEF and WHO statements above in Milestones]

::::::
 
WHO Grade 2 Emergencies  [to 11 November 2017]
Myanmar
::  Mortality and Morbidity Weekly Bulletin(MMWB) Cox’s Bazar, Bangladesh Volume No 4: 05
November 2017

::::::
::::::
 
UN OCHA – L3 Emergencies
The UN and its humanitarian partners are currently responding to three ‘L3’ emergencies. This is the global humanitarian system’s classification for the response to the most severe, large-scale humanitarian crises. 
Syrian Arab Republic
:: 8 Nov 2017  Syria: Flash update on recent events – 8 November 2017

Yemen 
:: 6 Nov 2017  Yemen Humanitarian Bulletin Issue 28 | 29 October 2017
:: Statement by the Humanitarian Coordinator for Yemen, Jamie Mcgoldrick, on Continued Violence Affecting Civilians in Yemen [EN/AR] Sana’a, 5 November 2017
 
::::::

UN OCHA – Corporate Emergencies
When the USG/ERC declares a Corporate Emergency Response, all OCHA offices, branches and sections provide their full support to response activities both at HQ and in the field.
ROHINGYA CRISIS
:: ISCG Situation Update: Rohingya Refugee Crisis, Cox’s Bazar – 9 November 2017
613,000 new arrivals are reported as of 7 November, according to IOM Needs and Population Monitoring.
A note on methodology: The official situation report figures are tabulated using the IOM Needs and Population Monitoring Emergency Tracking. This exercise takes place each day by estimating new arrivals at the point of transit in and around different settlements. NPM reports figures three times a week to update the international community on influx.

::::::
::::::
 
Editor’s Note:
We will cluster these recent emergencies as below and continue to monitor the WHO webpages for updates and key developments.

MERS-CoV [to 11 November 2017]
http://www.who.int/emergencies/mers-cov/en/
DONs
Middle East respiratory syndrome coronavirus (MERS-CoV) – Oman
10 November 2017
 
Yellow Fever  [to 11 November 2017]
http://www.who.int/csr/disease/yellowfev/en/
[See Milestone above]
 
::::::
::::::
 
WHO & Regional Offices [to 11 November 2017]
Stop using antibiotics in healthy animals
7 November 2017 – To prevent the spread of antibiotic resistance, farmers and the food industry should stop using antibiotics to promote growth and prevent disease in healthy animals. Over-use and misuse of antibiotics contributes to the threat of antibiotic resistance. Sustained action across all sectors, including agriculture, is key to preventing the spread of antibiotic resistance.

Highlights
Facilitating access to paediatric treatment of Chagas disease
November 2017 – WHO and partners are working to make an essential antiparasitic medicine for treatment of Chagas disease widely accessible to children. Treatment with this medicine in the early stages of infection can cure the Chagas disease, but currently very few people are able to access diagnosis and treatment services.

WHO’s work on air pollution
November 2017 – From smog hanging over cities to smoke inside the home, air pollution poses a major threat to health and climate. The combined effects of ambient (outdoor) and household air pollution cause about 6.5 million premature deaths every year.

Triple drug therapy to accelerate elimination of lymphatic filariasis
November 2017 – WHO is recommending an alternative three-drug treatment to accelerate the global elimination of lymphatic filariasis, a disabling and disfiguring neglected tropical disease. The treatment, known as IDA, involves a combination of ivermectin, diethylcarbamazine citrate, and albendazole.
 
Evaluation of the election of the Director-General of WHO
November 2017 – The Sixty-fifth World Health Assembly decided, in resolution WHA65.15 (2012), that an evaluation, open to all Member States, will be conducted by the Executive Board within one year from the appointment of the next Director-General of WHO, to assess the efficacy of the revised process and methods for the election of the Director-General, in order to discuss any need for further enhancing fairness, transparency and equity among the Member States of the six regions of WHO.

::::::

GIN October 2017 pdf, 2.23Mb 10 November 2017

::::::

Weekly Epidemiological Record, 10 November 2017, vol. 92, 45 (pp. 681–700)
:: Progress report on the elimination of human onchocerciasis, 2016–2017
:: Country Immunization Information System Assessments (IISAs), in Kenya (2015) and Ghana (2016)

::::::
 
WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region AFRO
:: 10 November 2017  Botswana successfully concludes the IDSR national Training of Trainers (TOT) Workshop
:: Uganda and Kenya Hold Cross Border Meeting on Marburg Virus Disease 10 November 2017
:: Ghana celebrates World Mental Health Day
:: As Nigerian government Flags-off 2017/2018 Measles Vaccination Campaign, Kaduna state Governor’s children get vaccinated against measles disease.  09 November 2017
:: Mental health in the workplace: Commemoration of the World Mental Health Day in Swaziland
09 November 2017
:: Local Communities in Kween District Embrace Marburg Virus Disease Control Interventions
08 November 2017
:: Namibia’s ban on antibiotics in healthy animals drives meat exports  08 November 2017
:: Building capacity for reducing health inequalities: The Regional GER & SD Workshop kicks off in Tanzania  07 November 2017
:: South Sudan kick starts implementation of the 3rd Malaria Indicator Survey to assess progress in tackling the disease  07 November 2017
:: New Strategy Launched to Help Tackle Maternal, Child Deaths in Sierra Leone 06 November 2017

WHO Region of the Americas PAHO
:: Obesity, a key driver of diabetes (11/10/2017)

WHO South-East Asia Region SEARO
::  Bangladesh steps up vaccination for new Rohingya arrivals as measles cases rise  10 November 2017
[See Bangladesh in Emergencies above]

WHO European Region EURO
:: Meeting of European immunization programme managers offers innovative forum for exchange of ideas and experiences 09-11-2017
Over 170 immunization programme managers from 43 Member States of the WHO European Region came together on 24–27 October 2017 in Budva, Montenegro, for the biannual Immunization Programme Managers’ Meeting (PMM), organized by WHO/Europe. They focused on maintaining momentum towards the goals of the European Vaccine Action Plan (EVAP).
Participants received updates on the work of WHO and partners, informed WHO and each other about progress in their countries, and learned about innovative WHO projects to address ongoing challenges. The PMM covered many immunization-related topics using a variety of formats to ensure maximum information sharing and discussion…

:: New procedure to accredit regional non-State actors not in official relations with WHO to the WHO Regional Committee for Europe 08-11-2017
:: Ioannina becomes the first city in Greece to pilot integrated health and social services 08-11-2017
:: New studies of street food in Kyrgyzstan and Tajikistan show alarming levels of trans fat and salt 08-11-2017
:: Training supports Republic of Moldova and Ukraine in increasing access to lower-priced medicines 06-11-2017

WHO Western Pacific Region
:: Stop overuse and misuse of antibiotics: combat resistance  MANILA, 10 November 2017
 

CDC/ACIP [to 11 November 2017]

CDC/ACIP [to 11 November 2017]
http://www.cdc.gov/media/index.html
https://www.cdc.gov/vaccines/acip/index.html

MMWR News Synopsis for November 9, 2017
Country Immunization Information System Assessments — Kenya, 2015 and Ghana, 2016
Countries wanting to strengthen their national immunization programs by creating data quality improvement plans now have a model, due to the new WHO and CDC method for immunization information system assessments (IISAs) which was recently used for assessments in Kenya and Ghana. The availability, quality, and use of immunization data are widely considered to be cornerstones of successful national immunization programs. In 2015 and 2016, immunization information system assessments (IISAs) were conducted in Kenya and Ghana using a new WHO and CDC assessment method designed to identify the root causes of immunization data quality problems and assist in the development of improvement plans. In Kenya, this resulted in national and county target-setting workshops, with goals of strengthening support for 17 targeted counties. In Ghana, public health officials are piloting changes to improve the managerial and supervision skills of sub-district staff. They are also incorporating data quality content into pre-professional coursework for health students and continuing education for facility staff.